Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
17.94
+0.25 (1.41%)
At close: Mar 28, 2025, 4:00 PM
17.56
-0.38 (-2.12%)
After-hours: Mar 28, 2025, 7:53 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.08 billion as of March 28, 2025. Its market cap has decreased by -32.82% in one year.
Market Cap
1.08B
Enterprise Value
477.92M
1-Year Change
-32.82%
Ranking
Category
Stock Price
$17.94
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.08B, an increase of 867.78%. That is a compound annual growth rate of 28.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.08B | -9.69% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.66B |
| UnitedHealth Group | 471.76B |
| Johnson & Johnson | 394.47B |
| AbbVie | 362.98B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 226.85B |
| Merck & Co. | 225.37B |
| AstraZeneca | 225.00B |